Tadashi Kimura

4.7k total citations
161 papers, 3.5k citations indexed

About

Tadashi Kimura is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Tadashi Kimura has authored 161 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Reproductive Medicine, 63 papers in Obstetrics and Gynecology and 40 papers in Oncology. Recurrent topics in Tadashi Kimura's work include Ovarian cancer diagnosis and treatment (69 papers), Endometrial and Cervical Cancer Treatments (55 papers) and Endometriosis Research and Treatment (17 papers). Tadashi Kimura is often cited by papers focused on Ovarian cancer diagnosis and treatment (69 papers), Endometrial and Cervical Cancer Treatments (55 papers) and Endometriosis Research and Treatment (17 papers). Tadashi Kimura collaborates with scholars based in Japan, United States and Russia. Tadashi Kimura's co-authors include Seiji Mabuchi, Yuri Matsumoto, Kenjiro Sawada, Katsumi Kozasa, Hiromasa Kuroda, Mahiru Kawano, Tomoyuki Sasano, Ryoko Takahashi, Takayuki Enomoto and Fumiaki Isohashi and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Research.

In The Last Decade

Tadashi Kimura

155 papers receiving 3.5k citations

Peers

Tadashi Kimura
Julie K. Schwarz United States
Julie A. DeLoia United States
Matthew L. Anderson United States
William Gordon United States
Tadashi Kimura
Citations per year, relative to Tadashi Kimura Tadashi Kimura (= 1×) peers Tsuyoshi Saito

Countries citing papers authored by Tadashi Kimura

Since Specialization
Citations

This map shows the geographic impact of Tadashi Kimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadashi Kimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadashi Kimura more than expected).

Fields of papers citing papers by Tadashi Kimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tadashi Kimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadashi Kimura. The network helps show where Tadashi Kimura may publish in the future.

Co-authorship network of co-authors of Tadashi Kimura

This figure shows the co-authorship network connecting the top 25 collaborators of Tadashi Kimura. A scholar is included among the top collaborators of Tadashi Kimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tadashi Kimura. Tadashi Kimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fukuhara, Rie, Yoshihito Yokoyama, Keiko Koide, et al.. (2024). Sexual reproductive health and rights awareness among members of the Japan Society of Obstetrics and Gynecology. Journal of obstetrics and gynaecology research. 50(9). 1697–1702. 1 indexed citations
4.
Ito, Yu, Jumpei Kondo, Shinya Matsuzaki, et al.. (2022). Ex vivo chemosensitivity assay using primary ovarian cancer organoids for predicting clinical response and screening effective drugs. Human Cell. 36(2). 752–761. 4 indexed citations
5.
Kondo, Jumpei, Kunishige Onuma, Yu Ito, et al.. (2022). Polarity switching of ovarian cancer cell clusters via SRC family kinase is involved in the peritoneal dissemination. Cancer Science. 113(10). 3437–3448. 10 indexed citations
6.
Kimura, Tadashi. (2021). Stability and Safety of Inhibitor Cystine Knot Peptide, GTx1-15, from the Tarantula Spider Grammostola rosea. Toxins. 13(9). 621–621. 8 indexed citations
7.
Matsuzaki, Shinya, Satoshi Serada, Koji Matsuo, et al.. (2021). CD70 antibody‐drug conjugate: A potential novel therapeutic agent for ovarian cancer. Cancer Science. 112(9). 3655–3668. 13 indexed citations
8.
Matsui, Takahiro, Masafumi Mimura, Seiji Taniguchi, et al.. (2020). Nonlinear Optics with Near-Infrared Excitation Enable Real-Time Quantitative Diagnosis of Human Cervical Cancers. Cancer Research. 80(17). 3745–3754. 12 indexed citations
9.
Sasano, Tomoyuki, Seiji Mabuchi, Katsumi Kozasa, et al.. (2018). The Highly Metastatic Nature of Uterine Cervical/Endometrial Cancer Displaying Tumor-Related Leukocytosis: Clinical and Preclinical Investigations. Clinical Cancer Research. 24(16). 4018–4029. 40 indexed citations
10.
Yokoi, Eriko, Seiji Mabuchi, Kotaro Shimura, et al.. (2018). Lurbinectedin (PM01183), a selective inhibitor of active transcription, effectively eliminates both cancer cells and cancer stem cells in preclinical models of uterine cervical cancer. Investigational New Drugs. 37(5). 818–827. 20 indexed citations
11.
Komura, Naoko, Eriko Yokoi, Katsumi Kozasa, et al.. (2017). Prognostic significance of pretreatment leukocyte alterations in patients with epithelial ovarian cancer. 69(2). 538. 1 indexed citations
12.
Mabuchi, Seiji, et al.. (2016). Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients. Journal of Gynecologic Oncology. 28(1). e15–e15. 31 indexed citations
13.
Kinose, Yasuto, Kenjiro Sawada, Hiroshi Makino, et al.. (2015). IKKβ Regulates VEGF Expression and Is a Potential Therapeutic Target for Ovarian Cancer as an Antiangiogenic Treatment. Molecular Cancer Therapeutics. 14(4). 909–919. 23 indexed citations
14.
Miyakawa, Yoshitaka, Hirokazu Kashiwagi, Toshiro Takafuta, et al.. (2014). [Consensus report for the management of pregnancy with primary immune thrombocytopenia].. PubMed. 55(8). 934–47. 6 indexed citations
15.
Kanagawa, Takeshi, et al.. (2014). Interstitial Pregnancy Resulting in a Viable Infant Coexistent with Massive Perivillous Fibrin Deposition: A Case Report and Literature Review. American Journal of Perinatology Reports. 4(1). 29–32. 11 indexed citations
16.
Hisamatsu, Takeshi, Seiji Mabuchi, Yuri Matsumoto, et al.. (2013). Potential Role of mTORC2 as a Therapeutic Target in Clear Cell Carcinoma of the Ovary. Molecular Cancer Therapeutics. 12(7). 1367–1377. 37 indexed citations
17.
Ueda, Yutaka, Takayuki Enomoto, Toshihiro Kimura, et al.. (2013). Serum biomarkers for early detection of gynecologic cancers. Reproductive Endocrinology. 73–80. 10 indexed citations
18.
Matsuo, Koji, Todd Sheridan, Kiyoshi Yoshino, et al.. (2012). Significance of lymphovascular space invasion in epithelial ovarian cancer. Cancer Medicine. 1(2). 156–164. 36 indexed citations
19.
Mabuchi, Seiji, Takeshi Hisamatsu, Masami Hayashi, et al.. (2011). The Activity of Trabectedin As a Single Agent or in Combination with Everolimus for Clear Cell Carcinoma of the Ovary. Clinical Cancer Research. 17(13). 4462–4473. 29 indexed citations
20.
Mabuchi, Seiji, Fumiaki Isohashi, Yasuo Yoshioka, et al.. (2010). Prognostic Factors for Survival in Patients With Recurrent Cervical Cancer Previously Treated With Radiotherapy. International Journal of Gynecological Cancer. 20(5). 834–840. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026